How protein-based COVID vaccines could change the pandemic
Elie Dolgin • November 8, 2021
Jabs from Novavax and other biotech firms are coming. Scientists say they have a lot to offer.
Continue reading at Nature.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.